[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

RU2004127960A - Применение композиций витамина d - Google Patents

Применение композиций витамина d Download PDF

Info

Publication number
RU2004127960A
RU2004127960A RU2004127960/13A RU2004127960A RU2004127960A RU 2004127960 A RU2004127960 A RU 2004127960A RU 2004127960/13 A RU2004127960/13 A RU 2004127960/13A RU 2004127960 A RU2004127960 A RU 2004127960A RU 2004127960 A RU2004127960 A RU 2004127960A
Authority
RU
Russia
Prior art keywords
vitamin
hydroxy derivative
pigs
feed
compositions
Prior art date
Application number
RU2004127960/13A
Other languages
English (en)
Other versions
RU2352139C2 (ru
Inventor
СИМОЭ-НЮНЕ Карлос (FR)
СИМОЭ-НЮНЕ Карлос
М. ВЕБЕР Гильберт (CH)
М. ВЕБЕР Гильберт
Original Assignee
Дсм Ип Ассетс Б.В. (Nl)
Дсм Ип Ассетс Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34306779&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2004127960(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Дсм Ип Ассетс Б.В. (Nl), Дсм Ип Ассетс Б.В. filed Critical Дсм Ип Ассетс Б.В. (Nl)
Publication of RU2004127960A publication Critical patent/RU2004127960A/ru
Application granted granted Critical
Publication of RU2352139C2 publication Critical patent/RU2352139C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/174Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)

Claims (8)

1. Применение 25-гидрокси производного витамина D3 предпочтительно в сочетании с витамином D3 в составе корма или ветеринарной композиции для усиления прочности костей животных, в частности свиней.
2. Применение по п.1 комбинации 25-гидрокси производного витамина D3 и витамина D3.
3. Применение по п.1 или 2 для приготовления корма для свиней примерно от 10 до 100 мкг/кг витамина D3 и примерно от 200 до 4000 МЕ/кг витамина D3.
4. Способ повышения прочности костей у свиней, заключающийся в назначении при необходимости лечения примерно от 10 до 30 мкг/кг 25-гидрокси производного витамина D3 и дополнительно примерно от 300 до 2000 МЕ/кг витамина D3 в сутки.
5. Композиция, содержащая 25-гидрокси производное витамина D3 и витамин D3.
6. Композиция по п.5 в качестве корма для животных, например свиней.
7. Композиция по п.6, содержащая примерно от 10 до 100 мкг/кг 25-гидрокси производного витамина D3 и примерно от 200 до 4000 МЕ/кг витамина D3.
8. Композиция по п.5, являющаяся кормовым премиксом, например, для кормления свиней, содержащая примерно от 2 до 20 мг/кг 25-гидрокси производного витамин D3 и примерно от 40000 до 800000 МЕ/кг витамина D3.
RU2004127960/13A 2003-09-22 2004-09-21 Способ повышения прочности костей у свиней, соответствующая композиция, ее применение, кормовой продукт и премикс для свиней RU2352139C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03021362.3 2003-09-22
EP03021362 2003-09-22

Publications (2)

Publication Number Publication Date
RU2004127960A true RU2004127960A (ru) 2006-03-10
RU2352139C2 RU2352139C2 (ru) 2009-04-20

Family

ID=34306779

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004127960/13A RU2352139C2 (ru) 2003-09-22 2004-09-21 Способ повышения прочности костей у свиней, соответствующая композиция, ее применение, кормовой продукт и премикс для свиней

Country Status (14)

Country Link
US (2) US20050064018A1 (ru)
EP (1) EP1516540B1 (ru)
JP (2) JP5477997B2 (ru)
CN (1) CN1615890B (ru)
AU (1) AU2004212588B2 (ru)
CA (1) CA2482080C (ru)
DK (1) DK1516540T3 (ru)
ES (1) ES2392823T3 (ru)
MX (1) MXPA04009079A (ru)
NO (1) NO20043937L (ru)
NZ (1) NZ535433A (ru)
PL (1) PL1516540T3 (ru)
RU (1) RU2352139C2 (ru)
ZA (1) ZA200407609B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080080579A (ko) * 2005-11-25 2008-09-04 디에스엠 아이피 어셋츠 비.브이. 동물의 생명력을 향상시키기 위한 25-하이드록시 비타민d3의 용도
EP1993375B1 (en) * 2006-03-10 2017-04-12 DSM IP Assets B.V. Novel use of a nutraceutical compositions in animal feed
EP2061341A1 (en) * 2006-09-14 2009-05-27 DSMIP Assets B.V. Food supplementation composition containing one or more vitamin d3 compounds and one or more magnesium salts
US20110124608A1 (en) * 2007-08-07 2011-05-26 Thau Kiong Chung Use of 25-hydroxy vitamin d3 to increase muscle mass in mammals
US20110052707A1 (en) * 2008-02-12 2011-03-03 Neil Robert Buck Combination of vitamin d and 25-hydroxyvitamin d 3
KR20150139629A (ko) * 2008-02-13 2015-12-11 디에스엠 아이피 어셋츠 비.브이. 비타민 d와 25-하이드록시비타민 d3의 조합물
CN101951919A (zh) * 2008-02-13 2011-01-19 帝斯曼知识产权资产管理有限公司 维生素d3和25-羟基-维生素d3用于治疗骨质疏松症和改善骨矿物质密度的组合用途
EP2299842B1 (en) * 2008-06-19 2013-11-13 DSM IP Assets B.V. Use of 25-hydroxyvitamin d3 for the reduction of drip losses in meat
RU2498613C2 (ru) 2008-11-19 2013-11-20 ДСМ АйПи АССЕТС Б.В. Применение кантаксантина и/или 25-он-d3 для улучшения выводимости домашней птицы
ES2622369T3 (es) 2009-12-22 2017-07-06 Dsm Ip Assets B.V. Uso de cantaxantina y/o 25-OH D3 para la capacidad de reproducción y el rendimiento mejorados de los machos gallináceos
CN106924268A (zh) 2010-12-06 2017-07-07 帝斯曼知识产权资产管理有限公司 用25‑羟基‑维生素d3治疗与嗜酸性粒细胞趋化因子增高有关的病症
AU2012260824A1 (en) 2011-05-26 2013-11-14 Dsm Ip Assets B.V. Use of 25-hydroxy vitamin D3 to promote phosphorous utilisation in ruminants
US20150342222A1 (en) 2012-12-27 2015-12-03 Dsm Ip Assets B.V. Novel use of canthaxanthin and 25-hydroxy vitamin d3
CN104431356A (zh) * 2014-11-28 2015-03-25 新津邦得科技有限公司 后备母猪维生素预混合饲料
CN104905060B (zh) * 2015-06-10 2018-08-28 河南大陆农牧技术有限公司 一种适用于体重25-70公斤的青年猪饲料配方
CN107183378A (zh) * 2017-05-19 2017-09-22 赣州八维生物科技有限公司 羟基蛋氨酸钙和25‑羟基维生素d3在提高猪生长性能和繁殖性能的应用
CN109601718A (zh) * 2018-10-18 2019-04-12 山东海能生物工程有限公司 用于降低初生仔猪弱腿症发病率的组合物及其制备方法
WO2020191426A1 (en) * 2019-03-22 2020-10-01 Jake Stockfeed Pty Ltd Horse supplement
CN112655836A (zh) * 2020-12-18 2021-04-16 广西北海市旺海生物科技有限公司 一种有助于提高肉小鸡骨胳强度的配合饲料
CN112956601A (zh) * 2021-03-18 2021-06-15 中国农业大学 一种25-羟基维生素d3在提高仔猪品质中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3646203A (en) * 1969-04-30 1972-02-29 Wisconsin Alumni Res Found Method of treating milk fever in dairy cattle with 25-hydroxycholecalciferol
US3639596A (en) * 1969-07-14 1972-02-01 Wisconsin Alumni Res Found Method of treating leg weakness in fowl with 25-hydroxycholecalciferol
US5043170A (en) * 1989-02-14 1991-08-27 Hoffmann-La Roche Inc. Animal feed composition containing a vitamin D metabolite
WO1990009179A1 (en) * 1989-02-16 1990-08-23 University Of Georgia Research Foundation, Inc. Treatment of tibial dyschondroplasia
US5935624A (en) * 1995-02-06 1999-08-10 Wisconsin Alumni Research Foundation Low phosphorus animal feed containing 1α-hydroxylated vitamin D compounds and method of preparing
US5695794A (en) * 1995-08-10 1997-12-09 Amoco Corporation Use of 25-hydroxycholecalciferol in a dietary supplement process for ameliorating the effects of tibial dyschondroplasia in poultry while maintaining weight gain
US7632518B2 (en) * 2002-01-15 2009-12-15 Dsm Ip Assets B.V. 25-hydroxy vitamin D3 compositions
JP2007505637A (ja) * 2003-09-22 2007-03-15 ディーエスエム アイピー アセッツ ビー.ブイ. ビタミン含有ペットフード組成物

Also Published As

Publication number Publication date
CN1615890B (zh) 2012-06-13
EP1516540A1 (en) 2005-03-23
US20130316990A1 (en) 2013-11-28
MXPA04009079A (es) 2005-03-31
RU2352139C2 (ru) 2009-04-20
CA2482080C (en) 2012-10-30
JP2012176949A (ja) 2012-09-13
ES2392823T3 (es) 2012-12-14
US20050064018A1 (en) 2005-03-24
EP1516540B1 (en) 2012-09-26
DK1516540T3 (da) 2012-11-26
CN1615890A (zh) 2005-05-18
AU2004212588B2 (en) 2009-05-07
AU2004212588A1 (en) 2005-04-07
JP2005120078A (ja) 2005-05-12
ZA200407609B (en) 2005-11-30
NZ535433A (en) 2006-10-27
NO20043937L (no) 2005-03-23
CA2482080A1 (en) 2005-03-22
PL1516540T3 (pl) 2013-02-28
JP5477997B2 (ja) 2014-04-23

Similar Documents

Publication Publication Date Title
RU2004127960A (ru) Применение композиций витамина d
EP2272522A3 (en) Therapeutic compositions for use in prophylaxis or treatment of diarrheas
MXPA05010682A (es) Compuestos novedosos.
MY142029A (en) Phenoxyacetic acid derivatives
IL163831A (en) Derivatives of aminoindazoles, pharmaceutical compositions comprising them, process for their preparation and use thereof
EP1878725A3 (en) Pyrimidine derivatives and their use as CB2 modulators
MXPA04003858A (es) Antagonistas de mch para el tratamiento de obesidad.
IL183565A0 (en) 5ht2c receptor modulator compositions and methods of use
MXPA05004247A (es) Cromonas y derivados de cromona y usos de los mismos.
CA2078019A1 (en) Substance or composition and uses thereof
NZ544645A (en) Use of calcitonin in osteoarthritis
WO2007130886A3 (en) Nutritional supplement and use thereof
MY144897A (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
IL159714A (en) Pharmaceutical composition for oral delivery comprising a fragment of parathyroid hormone and 5-cnac
TW200505470A (en) Therapeutic agent
TW200501963A (en) Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
WO2004091591A3 (fr) Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives
WO2004067027A3 (en) Osteogenic composition
PL346143A1 (en) Tan-1057 derivatives
WO2004046096A3 (en) Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics
MXPA04005552A (es) Analogos de vitamina d.
US20050256080A1 (en) Method for reducing malodor of chondroitin
AU2003251729A1 (en) Use of antibodies against flt-1 for the treatment of osteoporosis
WO2005056520A8 (en) Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
AU2003224107A1 (en) Soluble composition containing sporopollenin and the use thereof